Objectives: The aim of this critical review was to evaluate whether commonly used biologic diagnostic parameters correspond to implant survival and peri-implantitis prevalence.
| INTRODUC TI ON
Dental implants are widely used to restore partial and full edentulism. Due to a continuous improvement of implant designs, implant surface topographies, and prosthetic components, implant dentistry today yields excellent long-term results in terms of implant survival. Doornewaard et al. (2017) performed a systematic review including papers with above 5-year follow-up yielding a 97.3% weighted implant survival rate. Numerous clinical studies with a 10-year followup yield survival rates of over 95% Degidi, Nardi & Piattelli, 2012; Fischer & Stenberg, 2012; Gotfredsen, 2012; Jemt, 2017) . For single tooth replacements on turned implants, cumulative survival rates of 96.8% after 17-19 years (Bergenblock, Andersson, Furst & Jemt, 2012) and 91.5% after 16-22 years (Dierens, Vandeweghe, Kisch, Nilner & De Bruyn, 2012) were reported. In fully edentulous jaws, a 97% implant survival after on average 14 years has been reported (Vandeweghe, Ferreira, Vermeersch, Marien & De Bruyn, 2016) . Up to 20 years, implant survival rates in the range of 80%-95% have been reported with turned implants in fully edentulous jaws (Astrand, Ahlqvist, Gunne & Nilson, 2008; Attard & Zarb, 2004; Ekelund, Lindquist, Carlsson & Jemt, 2003; Lindquist, Carlsson & Jemt, 1996) . Chappuis et al. (2013) reported in a prospective study 89.5% survival of titanium plasma-sprayed implants after 20 years of function in partially edentulous cases. Compared with the era of introduction of dental implants in clinical practice half a century ago, implant survival is today predictable, regardless of implant length, implant diameter, bone quality, available bone volume, surgical, or prosthetic treatment protocol (Buser, Sennerby & De Bruyn, 2017) . Apart from restoring function and esthetics, this has also affected patient-reported quality of life (De Bruyn, Raes, Matthys & Cosyn, 2015) .
This positivity has over the last decade been affected by the escalating discussion on peri-implantitis, which has divided the scientific community and risks to ruin the good reputation of implant dentistry. Some of these disagreements are related to the inconsistency in the case definition, case selection, and the variability in diagnostic thresholds for disease (Albrektsson, Chrcanovic, Ostman & Sennerby, 2017; Coli, Christiaens, Sennerby & Bruyn, 2017; . Two recent systematic reviews indicated that homogeneity in peri-implantitis reporting is still lacking. Tomasi and Derks (2012) listed nine different threshold levels for radiographic bone loss applied to diagnose peri-implantitis, and Ramanauskaite and Juodzbalys (2016) detected 10 case definitions for peri-implantitis. It is doubtful whether this is beneficial for the patient in the long run given the clinical treatment consequences that may follow, which could lead to unnecessary surgical treatment or even implant removal.
It is evident that patient-related factors such as the inability to perform oral hygiene are related to peri-implantitis (Serino & Strom, 2009) , and regular maintenance is key for prevention (de Souza et al., 2013) . This is confirmed by a meta-analysis including 13 papers concluding that a more regular, individually tailored peri-implant maintenance therapy prevents possible biologic complications over time and improves the long-term outcome of implants . Recent systematic reviews scrutinized additional patient-related factors and their association with implant treatment outcome.
Among them, smoking habits have been shown to affect implant failure irrespective of implant surface, increase the risk of postoperative infection, and yield more marginal bone loss especially in the maxilla (Chrcanovic, Albrektsson & Wennerberg, 2015) . The history of periodontal disease was suggested as a second important patient-related factor. An increased susceptibility for periodontitis may translate into an increased susceptibility for implant loss, loss of supporting bone, and/or postoperative infection . No significant relation could be identified between diabetes and implant failure as no differences were observed between patients with and without diabetes . As concluded in multiple articles, the difference in occlusal loading between immediate non-functional and immediate functional loading may not affect the survival of these implants and no significant effect on the marginal bone loss has been reported . Furthermore, peri-implant mucositis can also be induced by residual cement in the sulcus (Linkevicius et al., 2013) or be related to implant/prosthetic factors and lead to peri-implantitis (Pesce et al., 2015) . In a systematic review including 79 papers (Doornewaard et al., 2017) , it was suggested that the implant factor surface roughness had an impact on peri-implant bone loss. The bone loss around the moderately rough and minimally rough surface implants was less than around rough surface implants. The additional meta-analysis confirmed that a history of periodontal disease and smoking leads to more peri-implant bone loss.
| Definition of peri-implant disease
Peri-implant mucositis is defined by the 6th European Workshop of Periodontology as a reversible inflammation of the peri-implant soft tissue with no signs of loss of the supporting bone. In the 7th European Workshop, it was diagnosed as bleeding on gentle probing (Lang, Berglundh, & Working Group 4 
of Seventh European
Workshop on Periodontology, 2011). Peri-implantitis is defined as inflammation of the soft tissues in combination with ongoing loss of the supporting peri-implant bone beyond the physiological bone adaptation (Lindhe, Meyle, & Group D of European Workshop on Periodontology, 2008) . The latter takes place as a consequence of biologic width establishment during initial healing. In the 3rd EAO consensus conference, it was stated that this initial bone remodeling may be unrelated to infection and is not necessarily peri-implantitis (Klinge, Meyle & Working, 2012) . It was therefore suggested that monitoring of implant performance should not be based on radiographs taken after implant placement but should relate to baseline recordings once tissue homeostasis has been established, in essence 3 months after completion of the treatment (Klinge et al., 2012) .
Today, there is a general consensus that a baseline radiograph is required for the assessment of bone changes over time (Lang, et al., 2011) . It is unfortunate that, this baseline radiograph is not always available when clinicians assess the peri-implant tissue condition.
For these conditions, a pragmatic clinical approach for peri-implantitis diagnosis was suggested by the 8th European Workshop for Periodontology (Sanz, Chapple, & Working Group 4 of the VIII European Workshop on Periodontology, 2012). The consensus report suggested a 2 mm additional loss beyond the "expected" bone level as a threshold in situations where baseline radiographic bone level assessment is lacking.
| Bone loss
Although the threshold for bone loss as a diagnostic criterion for disease is not exactly specified in the previous EFP or EAO consensus meetings, there is agreement on the fact that stable crestal bone levels are most important for implant success because it is paramount for long-term survival, esthetics, as well as peri-implant health. Klinge et al. (2012) advised that critical bone loss ≥2 mm from the time of placement of the prosthetic device, in combination with bleeding on probing, should be interpreted as a "red flag" for the clinician to critically evaluate whether any intervention is indicated in the individual case and whether follow-up and reassessment are required to confirm ongoing bone loss.
De Bruyn, Vandeweghe, Ruyffelaert, Cosyn and Sennerby (2013) reviewed radiographic assessment of modern implants and suggested that this mean bone loss assessment in patients with multiple implants yields very limited information on the condition of individual implants. However, it may be valid to benchmark implant systems. Given the fact that a majority of implants have very stable crestal bone levels over time and in a majority of cases sometimes no bone loss at all, the statistical interpretation of mean values often hides the condition of individual implants. It may be the reason why in the early studies, with mostly multiple implant cases for complete jaw rehabilitations, disease may have been overlooked. This is obvious from a radiographic follow-up study of 640 patients with 3,462 turned implants (Pikner, Grondahl, Jemt & Friberg, 2009 ). The mean bone loss after 5 years was 0.8 mm, and insignificant changes were reported in the years thereafter. However, the prevalence of implants with bone level located 3 mm apical to the implant-abutment junction was 2.8% at the time of prosthesis insertion but increased to 5.6%, 10.8%, 15.2%, 17.2%, and 23.5% after 1, 5, 10, 15, and 20 years, respectively. Vervaeke, Collaert, Cosyn and De Bruyn (2016) performed a prospective study, whereby 50 full-arch rehabilitations were immediately loaded the day of surgery on 5-8 implants in the maxilla and mandible and followed for 9 years. Implant survival was 99.2%, and the total mean bone loss, including initial remodeling, was calculated on patient level being limited to 1.7 mm.
However, on implant level, 30% of the individual implants had lost more than 2 mm, figures largely affected by the inclusion of smokers and patients with a periodontal history. Hence, in the context of peri-implantitis, the mean crestal bone values calculated on patient level are not appropriate to detect disease around individual implants. The same holds true for cross-sectional evaluation at a given time point when the baseline radiograph is lacking and bone levels are used as surrogate for peri-implantitis detection. A recent report of Pettersson and Sennerby (2015) revealed that 15% of the implants showed more than 2 mm bone loss after 5 years. Applying the criteria of Sanz, et al. (2012) , these implants could be diagnosed with peri-implantitis. However, in this particular study, 25% of the implants had already bone loss up to 2 mm due to the specific implant design and over time there was stability or even improvement of the bone level.
| Probing depth
Periodontal probing is a common basic diagnostic tool in periodontal diagnosis around teeth. Ericsson and Lindhe (1993) had described distinct differences between teeth and implants in soft tissue composition, organization, and attachment between the gingiva and the root surface on one hand and between the peri-implant mucosa and the implant surface on the other. Therefore, this affects the interpretation of probing depth measurements. In healthy tissue, the probe penetration is more advanced around implants (Eickholz, Grotkamp, Steveling, Muhling & Staehle, 2001; Ericsson, 1986; Klinge, 1991) although this is depending on the probing force (Lang, Wetzel, Stich & Caffesse, 1994) . Soft tissue around implants has also been found thicker than around teeth. This was first described in animals (Berglundh et al., 1991) and confirmed by human biopsies (Tomasi et al., 2014) . Parpaiola et al. (2015) assessed the dimensions of the soft tissue cuff present at various aspects around teeth and implants using human biopsies. The soft tissue cuff that surrounded a tooth varied between 2 mm at flat surfaces and 4 mm at proximal surfaces, while at implant sites, the mucosa at proximal as well as flat surfaces was 1-1.5 mm greater. The probing depth (PD) was greater at proximal than at facial or palatal/lingual surfaces at tooth sites and frequently also at implant sites. Furthermore, the PD and the soft tissue thickness were greater at implant than at adjacent tooth sites.
Another study (Choquet et al., 2001 ) confirmed soft tissue thickness ranging between 0.85 mm and 6.85 mm and papilla heights of 7 mm to 9 mm under healthy conditions. Kan, Rungcharassaeng, Umezu and Kois (2003) measured an average interproximal thickness of the mucosa of 6 mm with a large range. Gallucci, Belser, Bernard and Magne (2004) found mesial and distal PD often ranging between 4 and 8 mm depending on how scalloped the mucosa is. Animal studies have shown that conditions of mild inflammation already yield deeper pockets around implants compared to teeth and this does not necessarily coincide with actual bone loss (Schou et al., 2002) . A multilevel analysis performed in a group of 52 patients with screwretained restorations on 92 implants revealed that deeper PD is associated with higher tendency to bleed. This would indicate that an increase in PD in the absence of additional bone loss may be indicative of peri-implant mucositis (Klinge, 1991) . Also, Lang et al. (1994) concluded that the probe penetrates into the connective tissue in situations of mucositis. A few studies have looked for correlations between bone loss and clinical parameters among them probing.
They concluded that probing depths are of limited value in predicting future peri-implant bone loss (Dierens et al., 2012; Giannopoulou, Bernard, Buser, Carrel & Belser, 2003; Weber, Crohin & Fiorellini, 2000) . Long-term clinical studies have clearly shown that the probing depth of healthy peri-implant mucosa is not always smaller than 4 mm but very often up to 6 mm (Dierens et al., 2012; Karoussis et al., 2004; Lekholm et al., 1986) . In an 18-year follow-up of single turned implants, pockets of up to 9 mm were found despite the absence of bone loss (Bergenblock et al., 2012) . Also, Dierens et al. (2012) could not demonstrate correlations between PD and marginal bone levels around single implants functional for [16] [17] [18] [19] [20] [21] [22] and shallow (<4 mm) pockets were found in all bone level groups explaining the poor predictive value of probing in the peri-implantitis diagnosis when based on bone loss alone.
Probing is hindered by the location of the implant restoration especially in case of partial or full jaw reconstructions. This may be the reason while in some studies patients with multiple implant cases are diagnosed more often with peri-implantitis. Dalago, Schuldt Filho, Rodrigues, Renvert and Bianchini (2017) speculated that this could be attributed to less adequate oral hygiene or possible inclusion of more patients with periodontal history. Also, Serino and Strom (2009) proved that 65% of the implants with no good accessibility for oral hygiene showed peri-implantitis compared to 18% when oral hygiene was feasible. It is obvious that incorrect probing may lead to iatrogenic bleeding. De Bruyn, Bouvry, et al. (2013) evaluated full jaw patients with implants placed in onlay grafts in the maxilla after a mean follow-up of more than 9 years. To assess the peri-implant health, they removed the screw-retained reconstruction; 11% of the implants presented with a PD ≥ 5 mm despite more than 39% of the implants with BoP. There was no correlation between the registered BoP 39% and the bone loss, but the PD reflected the bone loss. Serino, Turri and Lang (2013) demonstrated differences in PD with or without the implant construction in place. The PD showed a high correlation with bone loss when the reconstruction was removed. The presence of the construction impeded the accuracy of the PD registration, and only in 37% of the sites, similar results were obtained with probing with or without the construction. They concluded that PD reflects the bony defect only when access for probing is ideal. However, full jaw prosthesis often present with overhang, which may lead to inaccurate probing and false-positive diagnosis. In addition, the measurement error encountered with probing is higher around implants than around teeth (Eickholz et al., 2001; Mombelli, Muhle, Bragger, Lang & Burgin, 1997) , and the type of implant may affect the absolute PD value.
The aforementioned studies all suggest that the use of an absolute PD threshold to diagnose the soft tissue around implants should be performed with great caution. Based on the current evidence, the PD value alone cannot be considered a reliable indicator for defining peri-implantitis (Serino et al., 2013) . When actual bone loss is not correctly taken into account, due to the absence of a baseline radiograph, and when the PD is the only determining factor in the diagnosis, this may undoubtedly account for the high reported prevalence of peri-implantitis in some studies. It is obvious that change in PD over time, once a physiological steady state in the soft tissue has been established, may be regarded as an indicator of disease activity. Huang et al. (2013) suggested that a baseline PD should be established as a basis for comparison over time because initial implant location may affect the PD. A recent systematic review (Lee, Huang, Zhu & Weltman, 2017) concluded that the use of progressively deepening probing depth is more meaningful than using absolute PD values of ≥4 or 5 mm.
| Bleeding on probing
Bleeding on probing is used in periodontal diagnosis. It is a poor predictor of disease progression, but the absence of BoP is a good predictor of future tissue stability (Lang, Adler, Joss & Nyman, 1990) . Lekholm et al. (1986) reported that neither deep pockets nor BoP was found to be accompanied by accelerated marginal bone loss. The probability of a peri-implant site to bleed upon probing is associated with PD, implant position and gender (Farina, Filippi, Brazzioli, Tomasi & Trombelli, 2017) . Jepsen, Ruhling, Jepsen, Ohlenbusch and Albers (1996) found no difference in BoP between sites with progressive bone loss or stable sites. They pointed out that probing might also provoke a nonspecific bleeding that is unrelated to the amount of inflammation and most probably related to the presence of the microgap between implants and abutments or reconstruction. Indeed, studies comparing teeth and implants, with respect to soft tissue healing, revealed that peri-implant healing as determined by crevicular molecular composition differs from periodontal healing. It is suggested that peri-implant tissues represent a higher pro-inflammatory state (Emecen-Huja et al., 2013 ).
An analysis of 987 implants followed for 9-14 years demonstrates that signs of mucositis (BoP) are evenly distributed among implants with or without peri-implantitis. There was actually no difference in the proportion of implants with the absence or presence of bleeding/suppuration in relation to bone loss, bone gain, or bone stability (Roos-Jansaker, Lindahl, Renvert & Renvert, 2006) .
Another large cohort study, including 4,591 implants from 2,060 subjects, indicated that minimal bleeding did not correlate with bone loss but multipoint bleeding, profuse bleeding, or suppuration did (French, Cochran & Ofec, 2016) . The use of a dichotomous diagnostic criterion (bleeding yes or no) is probably the reason why often high figures of mucositis are reported. Dierens et al. (2012) revealed 80% of BoP-positive implants after 16-22 years of follow-up despite a prevalence of peri-implantitis as low as 5% and found no correlation between BoP and peri-implantitis. Renvert, Lindahl and Persson (2018) evaluated 86 individuals at an examination after 9-14 years and furthermore after 21-26 years of function; 58% of the individuals with no bone loss during the interval had been diagnosed with mucositis during the first examination.
On the other hand, nearly 22% of the patients without any sign of mucositis after 9-14 years had developed peri-implantitis at a later stage. Data analysis failed to show that a diagnosis of mucositis after 9-14 years was predictive for development of peri-implantitis after 21-26 years. This recent paper is in contradiction with the suggestion of Jepsen et al. (2015) that mucositis is a precursor for peri-implantitis. This contradiction does not imply that one should 
The number of papers and summarized relevant clinical information(Continued) (Continues) become negligent and should not strive for the prevention of mucositis with good oral hygiene.
| Prevalence of peri-implantitis
The prevalence of peri-implant diseases significantly varies among clinical studies due to the inconsistent definitions, reporting methods and study characteristics. One of the first publications on the prevalence of peri-implant diseases by Zitzmann and Berglundh (2008) based on only two cross-sectional studies reported 28-77% on patient level and 12-43% on implant sites with peri-implantitis. Mombelli, Muller and Cionca (2012) calculated the prevalence of peri-implantitis, based on 29 papers, in the order of 10% of the affected implants and 20% patients during 5-10 years after implant placement. Another review summarizing 10 papers reporting on the 10-year clinical outcome with implants treated by sandblasting, grit blasting, acid-etching, or combined treatments revealed that the survival was above 95% and <5% were diagnosed with purulent infection or peri-implantitis (Albrektsson, Buser & Sennerby, 2012) . A 10-year follow-up study including nearly 300 implants in 100 subjects revealed similar figures (Cecchinato, Parpaiola & Lindhe, 2014) . They concluded that implant sites with radiographically confirmed marginal bone loss of ≥1 mm were not common and that peri-implantitis defined as bone loss >0.5 mm, BoP in the selected papers, in combination with a high dropout rate and the use of bone levels at a cross-sectional time point instead of absolute bone loss. The systematic review of Lee et al. (2017) included 47 studies whereby the bone level thresholds for disease ranged from 1 to 5 mm and lead to a weighted mean implant-based and subject-based peri-implantitis of 9.2% and 19.8%, respectively.
| Aim
The aim of this critical review was to describe whether the commonly used biologic diagnostic parameters correspond to long-term outcome in terms of implant survival and reported peri-implantitis prevalence.
| MATERIAL AND ME THODS

| Search strategy
The focus of this study was on diagnostic aspects in relation to peri- 
| Data analysis
Papers were descriptively analyzed, and case definitions of peri-implantitis were extracted. Analysis was performed on implant level. In the overall statistical analysis of implant survival and bone loss, the number of implants was used to weight the study or study groups throughout this review. A bivariate correlation analysis was per- 
| RE SULTS
| Selection and data reporting
The search yielded 4.173 papers whereof 255 publications were selected for full article reading. At last, 41 fulfilled the inclusion criteria, and the extracted data are summarized in Table 1 . The peri-implantitis case definitions applied in the respective articles are illustrated in Table 2 . In total, 41 articles, 21 prospective and 20 retrospective, report on 56 treatment groups. They represent in total 4,198 patients initially treated with 9,657 implants of various brands and with a variety of treatment protocols. A total of 6,246 implants were retrospectively analyzed, and 3,411 implants were prospectively analyzed. Table 3 shows the number of papers and their respective reported parameters.
| Survival rate and follow-up time
Thirty-eight of the 41 papers reported on survival rate in 49 treatment groups. The overall weighted mean survival rate was 96.9%
[89.5%-100%] and 97.2% and 96.2% for retrospective and prospective studies, respectively. In 39 and nine treatment groups, the reported implant survival rate was ranging between 95.0%-100% and 90.0%-94.9%, respectively. Only one treatment group reported an implant survival below 90%. The weighted mean follow-up time for the 56 treatment groups was 9.0 years with a range of 3-24.4 years.
The weighted mean follow-up was 9.2 (3-24.4) and 8.7 (5-21) years for retrospective and prospective groups, respectively. Thirty of the 56 treatment groups, representing initially 5886 implants, had a follow-up time between 5 and 9.9 years with 4,894 implants at follow-up (dropout 16.9%). In total, 24 treatment groups had a mean follow-up time ranging between 10 and 14.9 years, with 3,498 implants at baseline and 3,025 implants at follow-up (dropout 13.5%).
Only two treatment groups had a mean follow-up time of 15 years or longer, with 273 implants at baseline and 263 at follow-up (dropout rate of 3.7%).
| Reported prevalence and case definition of peri-implantitis
For all the included 56 treatment groups, the prevalence of periimplantitis on implant level ranged between 0% and 39.7% as shown in Table 1 BoP and/or suppuration with a bone loss threshold of 0.5 mm and diagnosed 24.9% with peri-implantitis. However, when they used a bone loss threshold of 2.0 mm, only 7.8% of the implants were diagnosed with peri-implantitis. Also, Donati et al. (2015) used two different bone loss thresholds. Peri-implantitis was diagnosed in 2.9% or 5.7% of the implants when applying 2 or 1 mm thresholds for bone loss, respectively. The highest prevalence of peri-implantitis (although coined incidence in the paper) was found in the study by Renvert, Lindahl and Rutger Persson (2012) , originally reporting on 234 implants of two different brands after 7 years of function in 54 patients. After 13 years, 164 implants were available for radiographic evaluation, which resulted in a dropout rate of 29.9% on implant level. The mean bone loss for the two study groups was 0.8 mm and 1.0 mm, respectively. Periimplantitis was detected in nearly 40% of the implants based on a bone loss threshold above 1 mm following the first year after implant placement.
| Mean bone loss
The weighted overall mean bone loss as reported in the papers was 
| Mean peri-implant probing depth and bleeding scores
In 25 papers, representing 34 treatment groups, the mean periimplant probing depth was reported. The overall mean weighted PD was 3.3 mm; 75% of the treatment groups reported a mean PD between 3.0 and 3.9 mm and only one treatment group reported a mean PD above 4 mm, whereas the majority of papers reported the mean PD, four papers gave a detailed frequency distribution as can be seen in Table 4 . Twenty-eight of the 41 included papers (38/56 treatment groups) reported mean bleeding scores around implants using various indices. Twenty-four papers (34/56 treatment groups) reported mean peri-implant bleeding on probing with a weighted mean of 52.2%, ranging from 4.7% to 95.0%.
The BoP around implants was <25% for 13 treatment groups, ranging from 25% to 49.9% for eight treatment groups and ranging from 50% to 74.9% for six treatment groups. In seven treatment groups, a BoP ≥ 75% was reported. Two papers reported the modified bleeding index (Mombelli, van Oosten, Schurch & Land, 1987) : one the Sulcus bleeding (Muhlemann & Son, 1971 ) and one TA B L E 2 Overview of the different definitions for peri-implantitis used in the retrieved papers. The article number refers to the reference provided in Table 1 Definition number 
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| Suppuration
Eight papers (Table 5) reported that 0%-20% of the implants showed suppuration independently from BoP. In four papers, this percentage corresponds nicely with the reported prevalence of peri-implantitis (~10%-40%), but in the other four papers, it did not. The high prevalence of 20% in the paper of Chappuis et al. (2013) is explained by the inclusion of six previously lost implants as well as 13 successfully treated ones. 
| Correlation between reported prevalence of peri-implantitis and biologic parameters
| D ISCUSS I ON
This review focused on reported peri-implantitis prevalence and diagnostic parameters considered important for long-term outcome. withstood the quality check. This is a disappointingly low proportion for a topic with such a significant impact for patients, clinicians, and implants industry.
The included material in this paper is strongly skewed toward retrospective studies, with 6,246 retrospective and 3,411 prospective analyzed implants. One could address that this leads to a higher inclusion of lower quality data. The high amount of retrospective included implants is mainly caused by the large study of for peri-implantitis of both lost and functioning implants. Lops et al.
(2012) described eight of 257 (3.1%) implants with mobility due to severe peri-implantitis and ten other implants were successfully treated during the 20-year follow-up period. Chappuis et al. (2013) reported 19 of 95 implants (20%) with peri-implantitis whereof six implants were lost and 13 underwent a successful anti-infectious therapy and were maintained with no further signs of acute infection. Both studies included the treated peri-implantitis implants in the reported prevalence figures despite successful treatment. In the other 36 papers, prevalence of peri-implantitis was related to surviving implants and dropouts or lost implants prior to the moment of assessment are not taken into account. One can conclude that information of peri-implantitis in lost implants is scarce, and hence, the reported prevalence may be underestimated in the available literature.
In this review, the prevalence of peri-implantitis on implant level ranged between 0% and 40%. The case definitions varied considerably between studies, mostly due to heterogeneous thresholds for bone loss, ranging from any detectable bone loss to 3.5 mm.
This makes comparisons between studies difficult. Reflecting on the results presented in Table 6 , it is obvious that reported prevalence figures are larger when the threshold is low. Using the same implant design, Swedish studies that applied a threshold bone loss of approximately 0.5 mm concluded that 13%-25% of the implants were affected (Derks et al., 2016; Ekfeldt, Furst & Carlsson, 2017) .
Thresholds of bone loss of 2-3 mm yield much lower prevalence in the order of 5%-10%. However, the paper of Meijer, Raghoebar, de Waal and Vissink (2014) A serious problem in this review is the heterogeneity of the data and the variation of the follow-up time within each study. This was recognized by previous authors (Frisch, Ziebolz & Rinke, 2013; Trullenque-Eriksson & Guisado-Moya, 2014) and obvious from the study of Jensen, Meijer, Raghoebar, Kerdijk and Cune (2017) . The latter had a mean follow-up time of 8 years based on implants in function from 3 years up to 16 years of follow-up. One could debate whether it is appropriate to sample implants with a large range in function time as being one group or whether cohort analysis based on function periods would be more justified.
Bone loss is in most of the studies expressed as a mean value with a standard deviation, which may hide outliers in the analysis.
When reporting mean values of bone loss in a study population, it implies that the data are normally distributed. If this were the case, the mean and standard deviation would suffice to estimate the percentage of implants with a defined bone loss. Doornewaard et al. (2017) applied this in a systematic review and calculated the proportion of implants with bone loss over 1, 2 and 3 mm, respectively.
The same approach was applied as a post hoc analysis using the 13 papers that reported both the mean and standard deviation and also TA B L E 5 Suppurating implants (%) in relation to the reported peri-implantitis prevalence. The article number refers to the reference provided in Table 1 Article number Author ( Table 1 gave a frequency distribution of bone loss as presented in Table 6 .
We observed that the calculated proportion of implants with bone loss was an overestimation when compared to the frequency distribution reported. Hence, bone loss is probably not normally distributed within the study population but positively skewed. Hence, nonparametric statistics is appropriate including statistical parameters median, interquartile ranges as well as frequency distributions.
This could refine the pre valence figures in scientific reports. Only four of the 13 previously mentioned papers reported their data in this proposed way (Donati et al., 2015; Ekfeldt et al., 2017; Frisch et al., 2013; van Velzen, Ofec, Schulten & Ten Bruggenkate, 2015) and all reported lower medians than means. This may suggest that few implants with an extensive bone loss have a big impact on the mean and the standard deviation. This is confirmed by Donati et al. TA B L E 6 Overview of studies giving a frequency distribution for implants with bone loss >2 mm in relation to prevalence of peri-implantitis and cutoff bone loss. The article number refers to the reference provided in Table 1 Article number
Author ( -a downhill Kaplan-Meier survival rate in relation to follow-up time (Meyle et al., 2014; Shi et al., 2018 is well known that values of 6-9 mm PD have been described in association with long-term successful dental implants. Human studies have shown that in healthy peri-implant mucosa, the probing depths are in most of the cases (60%-63%) above 4 mm and even up to 6 mm (Bergenblock et al., 2012; Lekholm et al., 1986) . One should also keep in mind that the interproximal probing depth measurement is affected by a significant papilla regrowth after crown installation.
These findings support the importance of a combination of diagnostic parameters when diagnosing peri-implantitis.
This critical review revealed mean BoP ranging from 4.7%-95%. at implant sites. This increase was found to be significantly higher when compared to tooth sites (6.6%). A low probing force of 0.15N resulted in similar findings at implants and tooth sites. None of the selected papers gave detailed information on probing force. Only the paper by Chappuis et al. (2013) used the sulcus bleeding index instead of BoP. By doing so, there is no de-attachment of the mucosa around the implant as it is carried out without using a high force. This could explain the low bleeding score. Merli et al. (2017) evaluated the peri-implant BoP together with PD scoring. They observed a 39% BoP and an increase in odds ratio by 1.8 for each 1 mm increment of PD. For pockets of 3 mm, 30%-40%
were BoP-positive. Over 80% of the pockets of 7 mm were bleeding.
Also, Farina et al. (2017) confirmed an odds ratio for BoP of 1.6 for each 1 mm increment of PD. In both studies, also similar proportion of BoP-positive sites was detected for pockets of 4 mm (27%) and 7 mm (60%). It is therefore obvious that deeper pockets have a higher tendency to bleed. A recent large retrospective cohort study (French et al., 2016) (2016). They specified that suppuration was detected in implants with the highest bone loss and suggested it could be useful for clinical diagnosis. Confirmation in more studies seems essential to confirm this assumption.
| CON CLUS IONS
There is a large variation in the peri-implantitis case definitions, and reporting of biologic parameters is incomplete. Peri-implantitis prevalence did not correlate with diagnostic parameters mean PD, mean BoP, and mean bone loss. Only mean BoP correlated strong, with reported prevalence of peri-implantitis. Survival rate showed a substantial correlation with function time, with minor implant loss over time. Inconsistent reporting of peri-implantitis prevalence needs to be addressed, and an unambiguous case definition for peri-implantitis is of utmost importance for science as well as clinical practice.
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